Cancel
See Linkedin
Known information
- Was Chief Executive Officer of Athena Vision, a biotechnology company, from April 2015 to April 2016
- Served as managing director of Coltivare Ltd., a healthcare consulting company, from June 2013 to April 2015
- Was Executive Director and Chief Scientific Officer of Oxford BioMedica plc, a gene therapy company, from 2008 to 2013
- Focused on translational cancer research at the Institute of Cancer Research
- Has a B.S.C. in microbiology and virology from the University of Warwick
- Earned a M.S. in Immunology from Kings College London
- Completed a Ph.D. from the Imperial Cancer Research Fund laboratory studying ovarian cancer and cytokine biology
About MeiraGTx
MeiraGTx is a biotechnology firm specializing in the development of gene therapies for serious diseases, with a focus on inherited retinal diseases, neurodegenerative diseases, and severe forms of xerostomia.
Report inaccurate information
